Total debt rose to $48.8B (up from $42.1B in 2024Q1) and equity turned more negative to -$6.6B, pushing debt-to-assets to roughly 81% and current ratio down to 0.78, indicating a highly leveraged and thinly liquid balance sheet.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 14.96B | 13.56B | 16.41B | 14.93B | 13.64B | 13.54B | 12.33B | 11.2B | 10.21B | 9.98B | 9.09B | 9.23B | 8.93B | 8.04B | 7.76B | 7.23B | 6.92B | 6.58B | 6.3B | 6.21B | 6.08B | 5.21B | 4.68B | 4.82B | 4.5B | 4.14B | 4.45B | 3.6B | 3.86B | 4.42B | 4.41B |
| Cash & Short-Term Investments | 1.01B | 1.04B | 2.02B | 935M | 908M | 1.45B | 1.79B | 621M | 502M | 732M | 646M | 741M | 566M | 414M | 705M | 373M | 411M | 312M | 465M | 393M | 634M | 336M | 258M | 115M | 161M | 85M | 314M | 190M | 297M | 110M | 113M |
| Cash Only | 1.01B | 1.04B | 1.93B | 935M | 908M | 1.45B | 1.79B | 621M | 502M | 732M | 646M | 741M | 566M | 414M | 705M | 373M | 411M | 312M | 465M | 393M | 634M | 336M | 129M | 115M | 161M | 85M | 314M | 190M | 297M | 110M | 113M |
| Short-Term Investments | 0 | 0 | 88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 12.28B | 10.87B | 10.75B | 9.96B | 8.89B | 8.1B | 7.05B | 7.38B | 6.79B | 6.5B | 5.83B | 5.89B | 5.69B | 5.21B | 4.67B | 4.53B | 3.83B | 3.69B | 3.78B | 3.9B | 3.71B | 3.33B | 3.08B | 3.1B | 2.79B | 2.51B | 2.41B | 2.05B | 2.25B | 3.05B | 2.84B |
| Days Sales Outstanding | 52.52 | 52.47 | 55.58 | 55.95 | 53.88 | 50.29 | 49.94 | 52.47 | 53.09 | 54.41 | 51.25 | 54.17 | 56.3 | 55.61 | 51.65 | 50.9 | 45.58 | 44.84 | 48.63 | 52.93 | 53.08 | 49.73 | 47.88 | 51.8 | 51.58 | 51.09 | 52.72 | 44.94 | 43.86 | 59.23 | 52.1 |
| Inventory | 1.66B | 1.65B | 1.74B | 2.02B | 2.07B | 1.99B | 2.02B | 1.85B | 1.73B | 1.57B | 1.5B | 1.44B | 1.28B | 1.18B | 1.09B | 1.05B | 897M | 802M | 737M | 710M | 669M | 616M | 577M | 520M | 462M | 423M | 396M | 383M | 434M | 452M | 441M |
| Days Inventory Outstanding | 10.99 | 13.63 | 15.13 | 18.73 | 20.37 | 19.99 | 88.32 | 79.58 | 81.85 | 78.48 | 79.13 | 79.13 | 74.55 | 72.08 | 69.34 | 74.28 | 66 | 60.13 | 58.23 | 58.96 | 56.5 | 54.49 | 53.99 | - | - | - | - | - | - | - | 21.35 |
| Other Current Assets | 0 | 0 | 1.9B | 2.01B | 1.78B | 2.01B | 1.46B | 1.35B | 1.19B | 1.17B | 1.11B | 1.16B | 1.39B | 1.24B | 1.3B | 1.27B | 1.78B | 1.77B | 1.32B | 1.21B | 1.07B | 931M | 1.14B | 1.09B | 1.09B | 1.12B | 1.33B | 973M | 887M | 807M | 806M |
| Total Non-Current Assets | 45.58B | 47.16B | 43.1B | 41.28B | 38.8B | 37.2B | 35.16B | 33.86B | 28.99B | 26.62B | 24.67B | 23.51B | 22.27B | 20.79B | 20.31B | 19.66B | 16.93B | 17.55B | 17.98B | 17.82B | 17.6B | 17.01B | 16.78B | 16.24B | 14.24B | 13.59B | 13.12B | 13.29B | 15.57B | 17.58B | 16.86B |
| Property, Plant & Equipment | 34.1B | 31.14B | 31.55B | 29.92B | 27.64B | 26.18B | 25.22B | 24.55B | 19.76B | 17.89B | 16.35B | 15.01B | 14.36B | 13.62B | 13.19B | 12.83B | 11.35B | 11.43B | 11.53B | 11.44B | 11.67B | 11.38B | 11.4B | 11.06B | 9.72B | 8.92B | 8.48B | 8.49B | 9.45B | 10.23B | 10.4B |
| Fixed Asset Turnover | 2.37x | 2.43x | 2.24x | 2.17x | 2.18x | 2.24x | 2.04x | 2.09x | 2.36x | 2.44x | 2.54x | 2.64x | 2.57x | 2.51x | 2.50x | 2.53x | 2.70x | 2.63x | 2.46x | 2.35x | 2.18x | 2.15x | 2.06x | 1.97x | 2.03x | 2.01x | 1.97x | 1.96x | 1.98x | 1.84x | 1.91x |
| Goodwill | 0 | 0 | 9.77B | 9.61B | 9.29B | 9.14B | 8.21B | 7.94B | 7.61B | 7.04B | 6.33B | 6.34B | 6.02B | 0 | 0 | 0 | 0 | 2.58B | 2.58B | 2.63B | 2.6B | 2.63B | 2.54B | 2.48B | 1.99B | 2.51B | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.66B | 10.29B | 323M | 339M | 359M | 403M | 369M | 330M | 342M | 359M | 374M | 393M | 399M | 5.9B | 5.54B | 5.25B | 2.69B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.41B | 2.05B | 2.25B | 3.05B | 2.84B |
| Long-Term Investments | 3.67B | 633M | 1.23B | 1.23B | 1.2B | 886M | 810M | 564M | 594M | 617M | 542M | 610M | 659M | 569M | 619M | 649M | 1.51B | 2.02B | 2.26B | 2.36B | 2.56B | 2.76B | 2.53B | 2.32B | 2.03B | 2.13B | 2.15B | 2.11B | 2.89B | 2.75B | 2.41B |
| Other Non-Current Assets | 0 | 5.09B | 230M | 184M | 298M | 598M | 546M | 480M | 690M | 710M | 1.07B | 1.16B | 620M | 703M | 969M | 931M | 1.38B | 1.53B | 1.61B | 1.39B | 762M | 244M | 313M | 378M | 487M | 486M | 330M | 368M | 318M | 1.08B | 550M |
| Total Assets | 60.53B | 60.72B | 59.51B | 56.21B | 52.44B | 50.74B | 47.49B | 45.06B | 39.21B | 36.59B | 33.76B | 32.74B | 31.2B | 28.83B | 28.07B | 26.9B | 23.85B | 24.13B | 24.28B | 24.02B | 23.68B | 22.23B | 21.46B | 21.06B | 18.74B | 17.73B | 17.57B | 16.89B | 19.43B | 22B | 21.27B |
| Asset Turnover | 1.29x | 1.25x | 1.19x | 1.16x | 1.15x | 1.16x | 1.09x | 1.14x | 1.19x | 1.19x | 1.23x | 1.21x | 1.18x | 1.19x | 1.18x | 1.21x | 1.29x | 1.25x | 1.17x | 1.12x | 1.08x | 1.10x | 1.09x | 1.04x | 1.05x | 1.01x | 0.95x | 0.99x | 0.96x | 0.86x | 0.94x |
| Asset Growth % | 6.95% | 2.03% | 5.87% | 7.2% | 3.34% | 6.85% | 5.4% | 14.92% | 7.14% | 8.4% | 3.1% | 4.95% | 8.21% | 2.69% | 4.38% | 12.77% | -1.16% | -0.61% | 1.06% | 1.48% | 6.52% | 3.54% | 1.91% | 12.39% | 5.7% | 0.92% | 4.04% | -13.09% | -11.69% | 3.43% | 6.94% |
| Total Current Liabilities | 19.14B | 16.35B | 15.18B | 12.65B | 9.9B | 9.58B | 8.7B | 7.76B | 7.57B | 6.16B | 5.83B | 5.52B | 5.48B | 5.7B | 6.17B | 5.55B | 4.27B | 4.31B | 3.91B | 3.85B | 3.58B | 3.9B | 3.17B | 3.17B | 3.74B | 3.18B | 4.14B | 3.33B | 3.56B | 2.77B | 2.95B |
| Accounts Payable | 4.75B | 4.66B | 4.28B | 4.23B | 4.24B | 4.11B | 3.54B | 2.9B | 2.58B | 2.61B | 2.32B | 2.17B | 2.04B | 1.8B | 1.77B | 1.6B | 1.54B | 1.46B | 1.37B | 1.37B | 1.42B | 1.48B | 855M | 877M | 809M | 755M | 693M | 657M | 784M | 929M | 790M |
| Days Payables Outstanding | 30.64 | 38.45 | 37.23 | 39.23 | 41.75 | 41.38 | 154.17 | 125.02 | 121.78 | 130.01 | 122.04 | 119.32 | 118.62 | 110.23 | 112.88 | 112.55 | 113.08 | 109.47 | 108.24 | 113.78 | 119.5 | 131.28 | 80 | - | - | - | - | - | - | - | 38.24 |
| Short-Term Debt | 8.1B | 6.74B | 4.7B | 2.42B | 370M | 237M | 209M | 145M | 788M | 200M | 216M | 233M | 338M | 786M | 1.44B | 1.41B | 592M | 846M | 404M | 308M | 293M | 586M | 486M | 665M | 446M | 807M | 1.12B | 1.16B | 1.07B | 132M | 201M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.9B | 2.42B | 910M | 867M | 794M | 549M | 547M | 528M | 459M | 67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46M |
| Current Ratio | 0.78x | 0.83x | 1.08x | 1.18x | 1.38x | 1.41x | 1.42x | 1.44x | 1.35x | 1.62x | 1.56x | 1.67x | 1.63x | 1.41x | 1.26x | 1.30x | 1.62x | 1.52x | 1.61x | 1.61x | 1.70x | 1.34x | 1.48x | 1.52x | 1.20x | 1.30x | 1.08x | 1.08x | 1.09x | 1.60x | 1.50x |
| Quick Ratio | 0.69x | 0.73x | 0.97x | 1.02x | 1.17x | 1.21x | 1.18x | 1.20x | 1.12x | 1.36x | 1.30x | 1.41x | 1.40x | 1.20x | 1.08x | 1.11x | 1.41x | 1.34x | 1.42x | 1.43x | 1.51x | 1.18x | 1.29x | 1.36x | 1.08x | 1.17x | 0.98x | 0.96x | 0.96x | 1.43x | 1.35x |
| Cash Conversion Cycle | 32.86 | 27.65 | 33.48 | 35.45 | 32.49 | 28.9 | -15.91 | 7.02 | 13.16 | 2.87 | 8.35 | 13.98 | 12.23 | 17.46 | 8.11 | 12.63 | -1.5 | -4.49 | -1.38 | -1.88 | -9.92 | -27.05 | 21.87 | - | - | - | - | - | - | - | 35.21 |
| Total Non-Current Liabilities | 44.53B | 47.14B | 43.78B | 42.5B | 42.61B | 39.67B | 35.89B | 37.87B | 34.56B | 35.43B | 33.56B | 33.27B | 32.22B | 30.06B | 30.24B | 28.36B | 30.38B | 27.8B | 29.63B | 29.78B | 30.57B | 12.64B | 13.07B | 11.01B | 8.69B | 9.22B | 8.45B | 7.17B | 7.52B | 11.14B | 8.88B |
| Long-Term Debt | 38.87B | 41.6B | 38.33B | 37.17B | 37.13B | 33.77B | 30.8B | 33.58B | 32.03B | 32.86B | 31.16B | 30.25B | 29.09B | 27.59B | 27.5B | 25.64B | 27.63B | 24.82B | 26.59B | 27B | 28.11B | 9.89B | 10.04B | 8.04B | 6.5B | 6.55B | 5.63B | 5.28B | 5.68B | 9.28B | 6.78B |
| Capital Lease Obligations | 7.32B | 1.85B | 1.86B | 1.9B | 2.33B | 2.33B | 1.67B | 1.5B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.72B | 1.61B | 1.77B | 1.78B | 1.38B | 1.02B | 1.41B | 1.75B | 1.65B | 999M | 0 | 0 | 0 | 0 | 0 | 2.1B |
| Other Non-Current Liabilities | 3.85B | 3.69B | 3.58B | 3.42B | 3.14B | 3.57B | 3.43B | 2.79B | 2.52B | 2.57B | 2.4B | 3.02B | 3.13B | 2.47B | 2.75B | 2.71B | 2.6B | 2.97B | 2.89B | 2.61B | 1.31B | 1.34B | 1.28B | 1.31B | 1.19B | 2.67B | 2.82B | 1.89B | 1.84B | 1.87B | 0 |
| Total Liabilities | 63.67B | 63.49B | 58.96B | 55.15B | 52.51B | 49.25B | 44.6B | 45.62B | 42.13B | 41.59B | 39.39B | 38.79B | 37.7B | 35.76B | 36.42B | 33.91B | 34.65B | 32.11B | 33.54B | 33.63B | 34.14B | 16.53B | 16.25B | 14.17B | 12.43B | 12.4B | 12.59B | 10.51B | 11.08B | 13.92B | 11.83B |
| Total Debt | 48.78B | 50.2B | 45.24B | 41.86B | 40.2B | 36.73B | 33.06B | 35.57B | 32.82B | 33.06B | 31.38B | 30.49B | 29.43B | 28.38B | 28.93B | 27.05B | 28.23B | 25.67B | 26.99B | 27.31B | 28.41B | 10.47B | 10.53B | 8.71B | 6.94B | 7.36B | 6.75B | 6.44B | 6.75B | 9.41B | 6.98B |
| Net Debt | 47.76B | 49.16B | 43.3B | 40.92B | 39.29B | 35.27B | 31.26B | 34.95B | 32.32B | 32.33B | 30.73B | 29.75B | 28.86B | 27.96B | 28.23B | 26.68B | 27.81B | 25.36B | 26.52B | 26.91B | 27.77B | 10.14B | 10.27B | 8.59B | 6.78B | 7.28B | 6.44B | 6.25B | 6.46B | 9.3B | 6.87B |
| Debt / Equity | -15.52x | - | 81.51x | 39.49x | - | 24.66x | 11.43x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.84x | 2.02x | 1.26x | 1.10x | 1.38x | 1.36x | 1.01x | 0.81x | 1.16x | 0.74x |
| Debt / EBITDA | 3.10x | 3.24x | 3.26x | 3.29x | 3.34x | 2.93x | 3.31x | 3.62x | 3.68x | 4.04x | 3.84x | 3.87x | 3.98x | 4.34x | 4.45x | 4.66x | 5.05x | 4.91x | 6.20x | 6.24x | 6.72x | 2.45x | 2.66x | 2.23x | 2.27x | 2.25x | 0.38x | 0.37x | 0.37x | 3.91x | 1.72x |
| Net Debt / EBITDA | 3.03x | 3.17x | 3.12x | 3.22x | 3.27x | 2.82x | 3.13x | 3.56x | 3.62x | 3.95x | 3.76x | 3.78x | 3.91x | 4.27x | 4.35x | 4.60x | 4.98x | 4.85x | 6.10x | 6.15x | 6.57x | 2.37x | 2.59x | 2.20x | 2.22x | 2.22x | 0.37x | 0.36x | 0.36x | 3.86x | 1.69x |
| Interest Coverage | 5.25x | 5.37x | 5.14x | 4.98x | 5.94x | 7.46x | 4.50x | 3.84x | 4.02x | 3.64x | 4.08x | 3.65x | 3.24x | 2.79x | 2.80x | 3.30x | 2.06x | 2.43x | 1.58x | 1.54x | 2.74x | 4.28x | 4.50x | - | - | - | - | - | - | - | - |
| Total Equity | -3.14B | -2.77B | 555M | 1.06B | -73M | 1.49B | 2.89B | -565M | -2.92B | -5B | -5.63B | -6.05B | -6.5B | -6.93B | -8.34B | -7.01B | -10.79B | -7.98B | -9.26B | -9.6B | -10.47B | 5.69B | 5.22B | 6.89B | 6.31B | 5.33B | 4.98B | 6.38B | 8.35B | 8.09B | 9.45B |
| Equity Growth % | -1707.67% | -599.28% | -47.64% | 1552.05% | -104.9% | -48.51% | 611.86% | 80.64% | 41.58% | 11.33% | 6.83% | 6.96% | 6.21% | 16.94% | -18.92% | 35.02% | -35.3% | 13.84% | 3.54% | 8.28% | -283.92% | 9.11% | -24.29% | 9.12% | 18.55% | 6.99% | -21.99% | -23.56% | 3.22% | -14.39% | 20.3% |
| Book Value per Share | -14.10 | -12.01 | 2.12 | 3.83 | -0.25 | 4.53 | 8.37 | -1.62 | -8.21 | -13.42 | -14.23 | -14.17 | -14.43 | -15.00 | -18.16 | -14.14 | -24.68 | -22.88 | -26.55 | -27.53 | -25.52 | 12.72 | 10.78 | 13.50 | 12.05 | 9.92 | 8.98 | 9.57 | 12.94 | 12.20 | 13.93 |
| Total Shareholders' Equity | -6.58B | -6.03B | -2.5B | -1.77B | -2.77B | -933M | 572M | -2.81B | -4.95B | -6.81B | -7.3B | -7.6B | -7.89B | -8.27B | -9.66B | -8.26B | -11.93B | -8.99B | -10.26B | -10.54B | -11.37B | 4.86B | 4.41B | 6.21B | 5.7B | 4.76B | 4.41B | 5.62B | 7.58B | 7.25B | 8.61B |
| Common Stock | 2M | 2M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 1M | 1M | 1M | 1M | 4M | 4M | 5M | 5M | 5M | 5M | 6M | 6M | 6M | 7M |
| Retained Earnings | -6.25B | -5.72B | -2.12B | -1.35B | -2.28B | -532M | 777M | -2.35B | -4.57B | -6.53B | -6.97B | -7.34B | -7.58B | -9.4B | -10.96B | -9.42B | -11.89B | -8.76B | -9.82B | -10.48B | -11.39B | 4.73B | 4.21B | 6.03B | 5.53B | 4.73B | 4.34B | 4.6B | 3.99B | 3.66B | 4.02B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -327M | -305M | -387M | -425M | -490M | -404M | -502M | -460M | -381M | -278M | -338M | -265M | -323M | -257M | -457M | -440M | -428M | -450M | -604M | -172M | 16M | 130M | 193M | 168M | 73M | 18M | 52M | 53M | 80M | 92M | -5.32B |
| Minority Interest | 3.43B | 3.26B | 3.05B | 2.83B | 2.69B | 2.42B | 2.32B | 2.24B | 2.03B | 1.81B | 1.67B | 1.55B | 1.4B | 1.34B | 1.32B | 1.24B | 1.13B | 1.01B | 995M | 938M | 907M | 828M | 809M | 680M | 611M | 563M | 572M | 763M | 765M | 836M | 836M |
Negative equity and high leverage
HCA's total debt climbed from $42.1B in 2024Q1 to $48.8B by 2026Q2, while equity turned more negative, according to recent SEC filings, indicating a balance sheet increasingly reliant on debt to fund growth.
The sequential increase in total debt, coupled with a widening negative equity position, suggests that HCA's aggressive capital deployment—likely for buybacks and capex—is outpacing retained earnings. This trend appears to be a deliberate strategy to leverage the balance sheet for shareholder returns, but it also raises the risk profile, especially if cash flows weaken. Investors should monitor whether this trajectory is sustainable given the company's high fixed costs and policy overhangs.
Total debt reached $48.8B in 2026Q2, up from $42.1B a year earlier, as reported in financial statements, pushing debt-to-assets to roughly 81% and signaling a highly leveraged capital structure.
The debt-to-assets ratio, which stood at 81% in 2026Q2, is elevated compared to peers like UHS (D/E 0.74) and THC (D/E 1.47), though HCA's scale and cash generation may support this leverage. The increase in debt appears strategic, funding buybacks and expansion, but it also exposes HCA to interest rate risk and refinancing needs. Given the company's negative equity, the debt load is a critical vulnerability that could constrain financial flexibility if operating conditions deteriorate.
PP&E grew to $34.1B in 2026Q2 from $30.3B in 2024Q1, while goodwill rose to $10.7B, as per balance sheet data, underscoring HCA's capital-intensive operations and acquisition-driven growth.
The steady increase in PP&E reflects ongoing investment in facilities and equipment, consistent with HCA's cluster strategy. Goodwill, now $10.7B, represents a significant portion of total assets and carries impairment risk if market conditions or regulatory changes impair expected cash flows. The asset mix indicates a heavy fixed-cost base, which amplifies operating leverage but also makes earnings sensitive to volume fluctuations.
Shareholders' equity fell to -$6.6B in 2026Q2 from -$1.6B in 2024Q1, according to the balance sheet, reflecting cumulative buybacks and losses that have eroded the equity base.
The negative equity is primarily driven by aggressive share repurchases, which have reduced the equity cushion, and retained earnings that remain negative. This structure is not uncommon for highly leveraged companies, but it means that HCA's solvency relies heavily on its ability to generate consistent cash flows. The trend suggests that management is prioritizing shareholder returns over balance sheet strength, which may be acceptable given the stable cash flows but warrants close monitoring.
The current ratio fell to 0.78 in 2026Q2 from 1.16 in 2024Q1, with cash at $1.0B, as reported in financial statements, indicating a tightening liquidity position relative to short-term obligations.
A current ratio below 1.0 suggests that HCA may struggle to cover short-term liabilities with current assets alone, though the company's robust operating cash flow provides an ongoing source of liquidity. The decline in the current ratio is partly due to increased debt and possibly higher payables, but it also reflects a deliberate strategy to minimize cash on hand. Given the high debt load, this thin buffer could be a concern if cash flows were to dip unexpectedly.
HCA's negative equity of -$6.6B in 2026Q2, as per the balance sheet, makes traditional D/E ratios meaningless, but the debt-to-assets ratio of 81% reveals a highly leveraged balance sheet.
The negative equity is a red flag that headline leverage metrics like D/E are not calculable, but it does not necessarily indicate distress given HCA's strong cash generation. However, it does mean that the company has no equity cushion to absorb losses, and any impairment or downturn could quickly erode solvency. This distortion warrants careful analysis of cash flow durability and the sustainability of the capital allocation strategy.
Quick answers to the most common questions about buying HCA stock.
As of 2025, HCA Healthcare, Inc. (HCA) had total assets of $60.72B including $13.56B in current assets.
HCA Healthcare, Inc. (HCA) carries total debt of $50.20B, offset by $1.04B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
HCA Healthcare, Inc. (HCA) has total shareholders' equity (book value) of $-6027.0M ($-12.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
HCA Healthcare, Inc. (HCA) reported a current ratio of 0.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.